Ophthalmic Devices Market Opportunities by 2020 – 2027

As per the research held by Acumen Research and Consulting, “the global Ophthalmic Devices market anticipated to exceed US$ 60.0 Bn by 2027, along with the projected CAGR of 6.2% from 2020 to 2027”.

The global Ophthalmic Devices market research report encompasses qualitative and quantitative data derived from the analysis by experts and research analysts in the respective industry verticals from valid sources with the help of primary and secondary research tools.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1849

The major market factors which are driving, hindering, challenging, or providing opportunities are specifically covered to better understand the market position, Recent market trends and governmental regulation & standards are additionally incorporated.

The research report has majorly profiled market information, DROs, segmentation, regional instance, and competitive landscape. The aforementioned entities further encompass prominent sections according to the need of the respective market. Moreover, regional segmentation includes North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and their respective major countries. The dipper information is profiled in terms of regions for getting recent and expected trends and opportunities in the regional market.

Furthermore, in terms of prominent players, the research report comprises a number of major players that are operating in the global competitive environment and offering advance and value-added products to the consumers. A detailed analysis is executed on these players in terms of the business snapshot, product offerings, financial overview, strategic development, player positioning, and R&D investment. This information is essential for the competitors and those who are planning to enter the market.

In a nutshell, the research report is a completely designed solution for those who are seeking information and available opportunities to take decisions of expansion in the desired market. As well as, the research report is also a value-added solution of the research students to get more specific information associated with the market.

Market participants

The players profiled in the report Topcon Corporation, Novartis AG, Carl Zeiss Meditec AG, HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., Essilor International S.A., Valeant Pharmaceuticals International, Inc., Hoya Corporation, Sonomed Escalon, FCI Ophthalmics, Glaukos Corporation, Ziemer Ophthalmic Systems AG, STAAR Surgical, and Gulden Ophthalmics.

Market segmentation

Market By Product Type

Ophthalmic Surgical Devices

  • Refractive Error Surgical Devices
    • Excimers and Femtosecond Lasers
    • Microkeratomes
  • Glaucoma Surgical Devices
    • Implants and Stents
    • Glaucoma Drainage
    • Glaucoma Laser Devices
  • Cataract Surgery Devices
    • Intraocular Lenses
    • Viscoelastics
    • Phacoemulsification Systems
  • Vitreoretinal Surgical Devices
    • Vitrectomy Machines & Vitrectomy Packs
    • Photocoagulation Lasers
    • Illumination Devices

Ophthalmic Diagnostic Devices

  • Refractors
  • Corneal Topography Systems
  • Retinal Ultrasound Systems
  • Fundus Camera
  • Ophthalmoscopes
  • Optical Coherence Tomography Systems
  • Perimeters
  • Slit Lamps
  • Tonometers

Ophthalmic Vision Care Devices

  • Contact Lenses
  • Spectacle Lenses

Market By Region

North America

  • US
  • Canada

Europe

  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest if Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Meddle East & Africa

Table of content

CHAPTER 1. INDUSTRY OVERVIEW 1.1. Definition and Scope 1.1.1. Definition of Ophthalmic Devices 1.1.2. Market Segmentation 1.1.3. List of Abbreviations 1.2. Summary 1.2.1. Market Snapshot 1.2.2. Ophthalmic Devices Market By Product Type 1.2.2.1. Global Ophthalmic Devices Market Revenue and Growth Rate Comparison By Product Type (2016-2027) 1.2.2.2. Global Ophthalmic Devices Market Revenue Share By Product Type in 2019 1.2.2.3. Ophthalmic Surgical Devices 1.2.2.3.1. Refractive Error Surgical Devices 1.2.2.3.1.1. Excimers and Femtosecond Lasers 1.2.2.3.1.2. Microkeratomes 1.2.2.3.2. Glaucoma Surgical Devices 1.2.2.3.2.1. Implants and Stents 1.2.2.3.2.2. Glaucoma Drainage 1.2.2.3.2.3. Glaucoma Laser Devices 1.2.2.3.3. Cataract Surgery Devices 1.2.2.3.3.1. Intraocular Lenses 1.2.2.3.3.2. Viscoelastics 1.2.2.3.3.3. Phacoemulsification Systems 1.2.2.3.4. Vitreoretinal Surgical Devices 1.2.2.3.4.1. Vitrectomy Machines & Vitrectomy Packs 1.2.2.3.4.2. Photocoagulation Lasers 1.2.2.3.4.3. Illumination Devices 1.2.2.4. Ophthalmic Diagnostic Devices 1.2.2.4.1. Refractors 1.2.2.4.2. Corneal Topography Systems 1.2.2.4.3. Retinal Ultrasound Systems 1.2.2.4.4. Fundus Camera 1.2.2.4.5. Ophthalmoscopes 1.2.2.4.6. Optical Coherence Tomography Systems 1.2.2.4.7. Perimeters 1.2.2.4.8. Slit Lamps 1.2.2.4.9. Tonometers 1.2.2.5. Ophthalmic Vision Care Devices 1.2.2.5.1. Contact Lenses 1.2.2.5.2. Spectacle Lenses 1.2.3. Ophthalmic Devices Market By Geography 1.2.3.1. Global Ophthalmic Devices Market Revenue and Growth Rate Comparison by Geography (2016-2027) 1.2.3.2. North America Ophthalmic Devices Market Revenue and Growth Rate(2016-2027) 1.2.3.3. Europe Ophthalmic Devices Market Revenue and Growth Rate(2016-2027) 1.2.3.4. Asia-Pacific Ophthalmic Devices Market Revenue and Growth Rate(2016-2027) 1.2.3.5. Latin America Ophthalmic Devices Market Revenue and Growth Rate(2016-2027) 1.2.3.6. Middle East and Africa (MEA)Ophthalmic Devices Market Revenue and Growth Rate(2016-2027)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS 2.1. Market Drivers 2.2. Restraints and Challenges 2.3. Growth Opportunities 2.4. Porter’s Five Forces Analysis 2.4.1. Bargaining Power of Suppliers 2.4.2. Bargaining Power of Buyers 2.4.3. Threat of Substitute 2.4.4. Threat of New Entrants 2.4.5. Degree of Competition 2.5. Value Chain Analysis 2.6. Cost Structure Analysis 2.6.1. Raw Material and Suppliers 2.6.2. Manufacturing Process Analysis 2.7. Regulatory Compliance 2.8. Competitive Landscape, 2019 2.8.1. Player Positioning Analysis 2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Commercial Production Date of Global Ophthalmic Devices Major Manufacturers in 2019 3.2. Manufacturing Plants Distribution of Global Ophthalmic Devices Major Manufacturers in 2019 3.3. R&D Status and Technology Source of Global Ophthalmic Devices Major Manufacturers in 2019 3.4. Raw Materials Sources Analysis of Global Ophthalmic Devices Major Manufacturers in 2019

CHAPTER 4. OPHTHALMIC DEVICES MARKET BY PRODUCT TYPE 4.1. Global Ophthalmic Devices Revenue By Product Type 4.2. Ophthalmic Surgical Devices 4.2.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million) 4.2.3. Refractive Error Surgical Devices 4.2.3.1. Excimers and Femtosecond Lasers 4.2.3.2. Microkeratomes 4.2.4. Glaucoma Surgical Devices 4.2.4.1. Implants and Stents 4.2.4.2. Glaucoma Drainage 4.2.4.3. Glaucoma Laser Devices 4.2.5. Cataract Surgery Devices 4.2.5.1. Intraocular Lenses 4.2.5.2. Viscoelastics 4.2.5.3. Phacoemulsification Systems 4.2.6. Vitreoretinal Surgical Devices 4.2.6.1. Vitrectomy Machines & Vitrectomy Packs 4.2.6.2. Photocoagulation Lasers 4.2.6.3. Illumination Devices 4.3. Ophthalmic Diagnostic Devices 4.3.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million) 4.3.3. Refractors 4.3.4. Corneal Topography Systems 4.3.5. Retinal Ultrasound Systems 4.3.6. Fundus Camera 4.3.7. Ophthalmoscopes 4.3.8. Optical Coherence Tomography Systems 4.3.9. Perimeters 4.3.10. Slit Lamps 4.3.11. Tonometers 4.4. Ophthalmic Vision Care Devices 4.4.1. Market Revenue and Growth Rate, 2016 – 2027 ($Million) 4.4.2. Market Revenue and Forecast, By Region, 2016 – 2027 ($Million) 4.4.3. Contact Lenses 4.4.4. Spectacle Lenses

CHAPTER 5. NORTH AMERICA OPHTHALMIC DEVICES MARKET BY COUNTRY 5.1. North America Ophthalmic Devices Market Revenue and Growth Rate, 2016 – 2027 ($Million) 5.2. North America Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%) 5.3. U.S. 5.3.1. U.S. Ophthalmic Devices Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 5.4. Canada 5.4.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million)

CHAPTER 6. EUROPE OPHTHALMIC DEVICES MARKET BY COUNTRY 6.1. Europe Ophthalmic Devices Market Revenue and Growth Rate, 2016 – 2027 ($Million) 6.2. Europe Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%) 6.3. UK 6.3.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 6.4. Germany 6.4.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 6.5. France 6.5.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 6.6. Spain 6.6.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 6.7. Rest of Europe 6.7.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million)

CHAPTER 7. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET BY COUNTRY 7.1. Asia-Pacific Ophthalmic Devices Market Revenue and Growth Rate, 2016 – 2027 ($Million) 7.2. Asia-Pacific Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%) 7.3. China 7.3.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 7.4. Japan 7.4.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 7.5. India 7.5.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 7.6. Australia 7.6.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 7.7. South Korea 7.7.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 7.8. Rest of Asia-Pacific 7.8.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million)

CHAPTER 8. LATIN AMERICA OPHTHALMIC DEVICES MARKET BY COUNTRY 8.1. Latin America Ophthalmic Devices Market Revenue and Growth Rate, 2016 – 2027 ($Million) 8.2. Latin America Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%) 8.3. Brazil 8.3.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 8.4. Mexico 8.4.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 8.5. Rest of Latin America 8.5.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million)

CHAPTER 9. MIDDLE EAST & AFRICA OPHTHALMIC DEVICES MARKET BY COUNTRY 9.1. Middle East & Africa Ophthalmic Devices Market Revenue and Growth Rate, 2016 – 2027 ($Million) 9.2. Middle East & Africa Ophthalmic Devices Market Revenue Share Comparison, 2016 & 2027 (%) 9.3. GCC 9.3.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 9.4. South Africa 9.4.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million) 9.5. Rest of Middle East & Africa 9.5.1. Market Revenue and Forecast By Product Type, 2016 – 2027 ($Million)

CHAPTER 10. COMPANY PROFILE 10.1. Topcon Corporation 10.1.1. Company Snapshot 10.1.2. Overview 10.1.3. Financial Overview 10.1.4. Product Portfolio 10.1.5. Key Developments 10.1.6. Strategies 10.2. Novartis AG 10.2.1. Company Snapshot 10.2.2. Overview 10.2.3. Financial Overview 10.2.4. Product Portfolio 10.2.5. Key Developments 10.2.6. Strategies 10.3. Carl Zeiss Meditec AG 10.3.1. Company Snapshot 10.3.2. Overview 10.3.3. Financial Overview 10.3.4. Product Portfolio 10.3.5. Key Developments 10.3.6. Strategies 10.4. HAAG-Streit Holding AG 10.4.1. Company Snapshot 10.4.2. Overview 10.4.3. Financial Overview 10.4.4. Product Portfolio 10.4.5. Key Developments 10.4.6. Strategies 10.5. Johnson & Johnson 10.5.1. Company Snapshot 10.5.2. Overview 10.5.3. Financial Overview 10.5.4. Product Portfolio 10.5.5. Key Developments 10.5.6. Strategies 10.6. Nidek Co., Ltd. 10.6.1. Company Snapshot 10.6.2. Overview 10.6.3. Financial Overview 10.6.4. Product Portfolio 10.6.5. Key Developments 10.6.6. Strategies 10.7. Essilor International S.A. 10.7.1. Company Snapshot 10.7.2. Overview 10.7.3. Financial Overview 10.7.4. Product Portfolio 10.7.5. Key Developments 10.7.6. Strategies 10.8. Valeant Pharmaceuticals International, Inc. 10.8.1. Company Snapshot 10.8.2. Overview 10.8.3. Financial Overview 10.8.4. Product Portfolio 10.8.5. Key Developments 10.8.6. Strategies 10.9. Hoya Corporation 10.9.1. Company Snapshot 10.9.2. Overview 10.9.3. Financial Overview 10.9.4. Product Portfolio 10.9.5. Key Developments 10.9.6. Strategies 10.10. Others 10.10.1. Company Snapshot 10.10.2. Overview 10.10.3. Financial Overview 10.10.4. Product Portfolio 10.10.5. Key Developments 10.10.6. Strategies

CHAPTER 11. RESEARCH APPROACH 11.1. Research Methodology 11.1.1. Initial Data Search 11.1.2. Secondary Research 11.1.3. Primary Research 11.2. Assumptions and Scope

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1849

Contact us:

Sheetal k

Email: sales@acumenresearchandconsulting.com

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com